GLP-1 medications like Ozempic and Wegovy are reshaping patient health and public discourse, as a study reveals that their increasing normalization reinforces dominant frameworks of weight stigma and individual responsibility, reflecting a structurally fatphobic narrative in Spain, which lacks acceptance of weight diversity and promotes a dichotomy between "good" and "bad" users based on perceived effort and morality. #GLP1 #WeightManagement #HealthDebate #ES
www.elperiodico.com
La popularizaciΓ³n del uso de Ozempic refuerza el estigma del sobrepeso segΓΊn un estudio universitario
Los medicamentos GLP-1, como Ozempic, Wegovy o Mounjaro, cada vez mΓ‘s extendidos, no solo estΓ‘n transformando la salud de los pacientes, sino tambiΓ©n el debate pΓΊblico.
